About Sunrest Lifescience Limited
Data last updated:
Sunrest Lifescience Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 30 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L74999GJ2017PLC099606. Its GSTIN is 24AAZCS4070Q1ZE (Gujarat). It is a listed company as per MCA records. Its shares are listed on NSE: SUNREST.
The company has an authorised share capital of ₹14 Cr and a paid-up capital of ₹4.29 Cr. It is led by directors including Nikhilkumar Yashvntlal Thakkar (Managing Director) and Amitbhai Shambhulal Thakkar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 07 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Ahmedabad, Gujarat.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹70.83 Cr, a growth of 112% compared to the previous year. For the same year it recorded a net profit of ₹1.51 Cr (net margin 2.1%) and EBITDA of ₹10.19 Cr (EBITDA margin 14.4%). The net worth stands at ₹20.43 Cr (up 25.3% YoY). Total assets are valued at ₹47.45 Cr (up 39.5% YoY).
The company has about 140 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sunrest Lifescience. As per MCA filings, the company has open charges of ₹16.49 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 2 cases are pending. The company has 2 deals on record (1 ipo, 1 secondary share transfer); the latest was in November 2023. Its 10 peer companies in the same principal business activity (wholesale trading) are compared by revenue, 5 larger and 5 smaller; the largest is Pesino Pharmaceuticals Private Limited with revenue of ₹29.51 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sunrestlifescience.com.
Company details
CIN history
Sunrest Lifescience has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L74999GJ2017PLC099606, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L74999GJ2017PLC099606 | Current |
| U74999GJ2017PTC099606 | Previous |
| U74999GJ2017PLC099606 | Previous |
Contact details
Sunrest Lifescience Limited's registered office is in Ahmadabad City, Gujarat.
- Registered AddressD – 608 West Gate Nr Brooklin Tower, Ymca Club Nr Sg Highway Makarba, Ahmedabad, Gujarat, India – 380051
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Sunrest Lifescience operates one associated brand: SUNREST LIFESCIENCE. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Healthcare and wellness products are offered via an online platform. | sunrestlifescience.com |
Business activity
The main business activity of Sunrest Lifescience is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sunrest Lifescience Limited, buy the company report.
Financials of Sunrest Lifescience Limited
FY 2025-26 filings availableSunrest Lifescience Limited reported revenue of ₹70.83 Cr (up 112% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Income statement | ||
| Revenue | 70.83 | 33.41 |
| Revenue growth | +112.0% | - |
| EBITDA | 10.19 | 3.02 |
| EBITDA margin | +14.4% | +9.0% |
| Profit before tax | 10.09 | 2.61 |
| Net profit | 1.51 | 1.99 |
| Net profit margin | +2.1% | +6.0% |
| EPS (₹) | 9.59 | 4.67 |
| Balance sheet | ||
| Total assets | 47.45 | 34.02 |
| Net worth | 20.43 | 16.31 |
| Total debt | 17.46 | 12.06 |
| Cash & bank | 2.76 | 1.74 |
| Net working capital | 38.50 | 28.96 |
| Cash flow | ||
| Cash from operations | (0.05) | 2.92 |
| Cash from investing | (2.91) | (1.15) |
| Cash from financing | 3.99 | (0.33) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 33.26 | 33.12 | 29.48 | 24.64 | 26.89 | 16.95 | 10.95 |
| Revenue growth | +0.4% | +12.4% | +19.6% | -8.4% | +58.6% | +54.8% | - |
| EBITDA | 4.82 | 3.00 | 0.90 | 2.91 | 1.11 | 0.27 | 0.15 |
| EBITDA margin | +14.5% | +9.1% | +3.1% | +11.8% | +4.1% | +1.6% | +1.4% |
| Profit before tax | 4.08 | 2.61 | 0.58 | 2.75 | 1.05 | 0.22 | 0.13 |
| Net profit | 3.09 | 2.00 | 0.22 | 2.05 | 0.76 | 0.17 | 0.03 |
| Net profit margin | +9.3% | +6.0% | +0.8% | +8.3% | +2.8% | +1.0% | +0.3% |
| EPS (₹) | 7.20 | 4.66 | 0.53 | 6.81 | 777.10 | 165.50 | 36.80 |
| Balance sheet | |||||||
| Total assets | 28.81 | 22.69 | 20.35 | 5.26 | 4.31 | 2.61 | 2.40 |
| Net worth | 19.27 | 16.18 | 14.18 | 3.11 | 1.07 | 0.29 | 0.13 |
| Total debt | 9.17 | 6.17 | 6.16 | 2.14 | 3.24 | 2.31 | 2.27 |
| Cash & bank | 0.51 | 0.28 | 0.29 | 0.45 | 0.48 | 0.37 | 0.34 |
| Net working capital | 20.56 | 15.80 | 20.01 | 4.85 | 3.82 | 2.45 | 2.37 |
| Cash flow | |||||||
| Cash from operations | (0.68) | 1.43 | (14.80) | 1.15 | (0.44) | 0.15 | (0.90) |
| Cash from investing | (1.58) | (1.14) | (0.01) | (0.03) | (0.36) | (0.16) | (0.01) |
| Cash from financing | 2.49 | (0.30) | 14.64 | (1.15) | 0.90 | 0.04 | 1.11 |
| Particulars | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|
| Revenue | 6.84 | 5.64 | 6.84 |
| Other income | 0.00 | 0.00 | 0.03 |
| Total expenses | 6.19 | 4.63 | 7.16 |
| EBITDA | 0.65 | 1.01 | (0.32) |
| EBITDA margin | +9.5% | +17.9% | -4.7% |
| Depreciation | 0.02 | 0.02 | 0.03 |
| Interest | 0.01 | 0.01 | 0.04 |
| Profit before tax | 0.62 | 0.98 | (0.36) |
| Tax | (0.62) | 0.22 | (0.04) |
Financial Statements
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Revenue | 70.83 | 33.41 |
| Revenue growth | +112.0% | - |
| Other income | 2.51 | 0.00 |
| Total expenses | 60.64 | 30.39 |
| Employee cost | 6.70 | 4.22 |
| EBITDA | 10.19 | 3.02 |
| EBITDA margin | +14.4% | +9.0% |
| Depreciation | 1.19 | 0.10 |
| Interest | 1.42 | 0.31 |
| Profit before tax | 10.09 | 2.61 |
| Tax | 2.11 | 0.61 |
| Net profit | 1.51 | 1.99 |
| Net profit margin | +2.1% | +6.0% |
| EPS (₹) | 9.59 | 4.67 |
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Equity & liabilities | ||
| Share capital | 4.29 | 4.29 |
| Reserves & surplus | 16.14 | 12.02 |
| Shareholders' funds (net worth) | 20.43 | 16.31 |
| Minority interest | 9.20 | 5.32 |
| Secured loans | 14.09 | 9.21 |
| Unsecured loans | 3.37 | 2.85 |
| Total debt | 17.46 | 12.06 |
| Total liabilities | 47.45 | 34.02 |
| Assets | ||
| Gross block | 10.07 | 5.11 |
| Net block | 8.55 | 4.36 |
| Capital work in progress | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 |
| Inventories | 17.06 | 9.62 |
| Sundry debtors | 32.46 | 36.37 |
| Cash & bank balances | 2.76 | 1.74 |
| Loans & advances | 10.18 | 5.86 |
| Total current assets | 62.46 | 53.59 |
| Total current liabilities | 23.96 | 24.63 |
| Net working capital | 38.50 | 28.96 |
| Total assets | 47.45 | 34.02 |
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Opening cash | 1.74 | 0.29 |
| Net cash from operating activities | (0.05) | 2.92 |
| Net cash from investing activities | (2.91) | (1.15) |
| Net cash from financing activities | 3.99 | (0.33) |
| Net change in cash | 1.03 | 1.45 |
| Closing cash | 2.76 | 1.74 |
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Growth | ||
| Sales growth | +112.0% | - |
| EBITDA growth | +237.4% | - |
| PBT growth | +286.6% | +9997.0% |
| Net income growth | -24.1% | - |
| Profitability & leverage | ||
| Net income margin | +11.3% | +6.0% |
| Return on capital employed | +28.0% | +10.2% |
| Return on net worth | +29.4% | +12.3% |
| Debt / equity | 0.80 | 0.74 |
| Long-term debt / equity | 0.48 | 0.35 |
| Interest cover | 15.78 | 10.62 |
| Efficiency & per share | ||
| Fixed asset turnover | 9.33 | 6.54 |
| Inventory turnover | 5.31 | 3.47 |
| Debtors turnover | 2.06 | 0.92 |
| EPS (₹) | 9.59 | 4.67 |
| Dividend per share (₹) | 0.00 | 0.00 |
| Book value per share (₹) | 47.60 | 38.01 |
| Particulars | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|
| Revenue | 6.84 | 5.64 | 6.84 |
| Other income | 0.00 | 0.00 | 0.03 |
| Total expenses | 6.19 | 4.63 | 7.16 |
| EBITDA | 0.65 | 1.01 | (0.32) |
| EBITDA margin | +9.5% | +17.9% | -4.7% |
| Depreciation | 0.02 | 0.02 | 0.03 |
| Interest | 0.01 | 0.01 | 0.04 |
| Profit before tax | 0.62 | 0.98 | (0.36) |
| Tax | (0.62) | 0.22 | (0.04) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 33.26 | 33.12 | 29.48 | 24.64 | 26.89 | 16.95 | 10.95 |
| Revenue growth | +0.4% | +12.4% | +19.6% | -8.4% | +58.6% | +54.8% | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.00 | 0.00 |
| Total expenses | 28.44 | 30.12 | 28.58 | 21.73 | 25.78 | 16.68 | 10.80 |
| Employee cost | 0.00 | 4.21 | 3.59 | 2.90 | 2.54 | 2.37 | 2.06 |
| EBITDA | 4.82 | 3.00 | 0.90 | 2.91 | 1.11 | 0.27 | 0.15 |
| EBITDA margin | +14.5% | +9.1% | +3.1% | +11.8% | +4.1% | +1.6% | +1.4% |
| Depreciation | 0.23 | 0.09 | 0.10 | 0.13 | 0.06 | 0.04 | 0.02 |
| Interest | 0.51 | 0.30 | 0.22 | 0.06 | 0.02 | 0.01 | 0.00 |
| Profit before tax | 4.08 | 2.61 | 0.58 | 2.75 | 1.05 | 0.22 | 0.13 |
| Tax | 0.99 | 0.61 | 0.36 | 0.70 | 0.27 | 0.05 | 0.10 |
| Net profit | 3.09 | 2.00 | 0.22 | 2.05 | 0.76 | 0.17 | 0.03 |
| Net profit margin | +9.3% | +6.0% | +0.8% | +8.3% | +2.8% | +1.0% | +0.3% |
| EPS (₹) | 7.20 | 4.66 | 0.53 | 6.81 | 777.10 | 165.50 | 36.80 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 4.29 | 4.29 | 4.29 | 3.00 | 0.01 | 0.01 | 0.01 |
| Reserves & surplus | 14.98 | 11.89 | 9.89 | 0.11 | 1.06 | 0.28 | 0.12 |
| Shareholders' funds (net worth) | 19.27 | 16.18 | 14.18 | 3.11 | 1.07 | 0.29 | 0.13 |
| Secured loans | 5.80 | 3.32 | 2.70 | 0.26 | 0.38 | 0.09 | 0.00 |
| Unsecured loans | 3.37 | 2.85 | 3.46 | 1.88 | 2.86 | 2.22 | 2.27 |
| Total debt | 9.17 | 6.17 | 6.16 | 2.14 | 3.24 | 2.31 | 2.27 |
| Total liabilities | 28.81 | 22.69 | 20.35 | 5.26 | 4.31 | 2.61 | 2.40 |
| Assets | |||||||
| Gross block | 3.08 | 1.50 | 0.53 | 0.53 | 0.51 | 0.19 | 0.06 |
| Net block | 2.67 | 1.33 | 0.26 | 0.35 | 0.46 | 0.15 | 0.03 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 5.52 | 5.52 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 |
| Inventories | 10.90 | 6.79 | 5.05 | 3.94 | 2.30 | 1.52 | 0.48 |
| Sundry debtors | 18.61 | 19.01 | 15.00 | 10.86 | 9.35 | 7.40 | 5.37 |
| Cash & bank balances | 0.51 | 0.28 | 0.29 | 0.45 | 0.48 | 0.37 | 0.34 |
| Loans & advances | 3.08 | 2.19 | 4.49 | 1.05 | 0.40 | 0.03 | 0.03 |
| Total current assets | 33.10 | 28.27 | 24.83 | 16.30 | 12.53 | 9.32 | 6.22 |
| Total current liabilities | 12.54 | 12.47 | 4.82 | 11.45 | 8.71 | 6.87 | 3.85 |
| Net working capital | 20.56 | 15.80 | 20.01 | 4.85 | 3.82 | 2.45 | 2.37 |
| Total assets | 28.81 | 22.69 | 20.35 | 5.26 | 4.31 | 2.61 | 2.40 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.28 | 0.29 | 0.45 | 0.48 | 0.37 | 0.34 | 0.14 |
| Net cash from operating activities | (0.68) | 1.43 | (14.80) | 1.15 | (0.44) | 0.15 | (0.90) |
| Net cash from investing activities | (1.58) | (1.14) | (0.01) | (0.03) | (0.36) | (0.16) | (0.01) |
| Net cash from financing activities | 2.49 | (0.30) | 14.64 | (1.15) | 0.90 | 0.04 | 1.11 |
| Net change in cash | 0.23 | (0.01) | (0.16) | (0.03) | 0.11 | 0.03 | 0.20 |
| Closing cash | 0.51 | 0.28 | 0.29 | 0.45 | 0.48 | 0.37 | 0.34 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +0.4% | +12.4% | +19.6% | -8.4% | +58.6% | +54.8% | - |
| EBITDA growth | +60.7% | +233.3% | -69.1% | +162.2% | +311.1% | +80.0% | - |
| PBT growth | +56.3% | +350.0% | -78.9% | +161.9% | +377.3% | +69.2% | +9997.0% |
| Net income growth | +54.5% | +809.1% | -89.3% | +169.7% | +347.1% | +466.7% | - |
| Revenue CAGR (3Y) | +10.5% | +7.2% | +20.3% | +31.0% | - | - | - |
| EBITDA CAGR (3Y) | +18.3% | +39.3% | +49.4% | +168.7% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +9.3% | +6.0% | +0.8% | +8.3% | +2.9% | +1.0% | +0.3% |
| Return on capital employed | - | +13.5% | +6.4% | +58.6% | +30.9% | +9.6% | +5.8% |
| Return on net worth | - | +13.2% | +2.7% | +97.6% | +114.7% | +81.0% | +30.8% |
| Debt / equity | - | 0.41 | 0.48 | 1.29 | 4.09 | 10.93 | 17.46 |
| Long-term debt / equity | - | 0.25 | 0.32 | 1.22 | 3.95 | 10.84 | 17.46 |
| Interest cover | 11.11 | 10.31 | 27.50 | 2.16 | 1.90 | 4.35 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 32.63 | 55.62 | 47.38 | 76.83 | 135.60 | 182.50 |
| Inventory turnover | - | 5.59 | 6.56 | 7.90 | 14.08 | 16.95 | 22.81 |
| Debtors turnover | - | 1.95 | 2.28 | 2.44 | 3.21 | 2.65 | 2.04 |
| EPS (₹) | 7.20 | 4.66 | 0.53 | 6.81 | 777.10 | 165.50 | 36.80 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 37.72 | 33.06 | 10.38 | 1,070.40 | 294.90 | 129.40 |
To see the full year-wise statements and ratios of Sunrest Lifescience Limited, buy the company report.
Board of directors of Sunrest Lifescience Limited
Sunrest Lifescience has 6 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amitbhai Shambhulal Thakkar | Whole-Time Director | 30 Oct 2017 | 8 Years 11 Months | Current |
| Bhagyesh Kiritbhai Parekh | Director | 31 Jan 2022 | 4 Years 8 Months | Current |
| Nikhilkumar Yashvntlal Thakkar | Managing Director | 30 Oct 2017 | 8 Years 11 Months | Current |
| Bharatkumar Vardhilal Thakkar | Director | 15 Mar 2021 | 5 Years 7 Months | Current |
| Juhi Sawajani Also directs: Kizi Apparels Limited, Ambassador Intra Holdings Limited, Bizotic Commercial Limited and 5 more | Director | 01 Mar 2023 | 3 Years 7 Months | Current |
| Avani Ashwinkumar Shah Also directs: Kizi Apparels Limited, Ambassador Intra Holdings Limited, Bright Solar Limited and 2 more | Director | 01 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Sunrest Lifescience Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunrest Lifescience Limitedthis company | ₹70.83 Cr (FY 2026) | ₹1.51 Cr | 2.1% | 112.0% | Ahmedabad, Gujarat, India | |
| Pesino Pharmaceuticals Private Limited | ₹29.51 Cr (FY 2024) | 50.0% | Mumbai, Maharashtra, India | |||
| Gattani Metals Private Limited | ₹29.51 Cr (FY 2025) | -26.0% | Jaipur, Rajasthan, India | |||
| Gopnath Gold Mint Private Limited | ₹29.51 Cr (FY 2025) | 378843.0% | Sanand, Gujarat, India | |||
| Celestial Industries Private Limited | ₹29.49 Cr (FY 2025) | -11.0% | New Delhi, Delhi, India | |||
| Shivansh Autozone Private Limited | ₹29.48 Cr (FY 2015) | 0.0% | Mandi, Himachal Pradesh, India | |||
| Compac Technologies India Limited | ₹29.48 Cr (FY 2025) | -19.0% | Ludhiana, Punjab, India | |||
| Thakorlal Hiralal Exports Private Limited | ₹29.48 Cr (FY 2025) | -6.0% | Mumbai, Maharashtra, India | |||
| Uco Global Ventures Private Limited | ₹29.47 Cr (FY 2025) | 17.0% | New Delhi, Delhi, India | |||
| Victor Rackets Private Limited | ₹29.46 Cr (FY 2025) | 79.0% | Gurgaon, Haryana, India | |||
| Marcopolo Sourcing Private Limited | ₹29.45 Cr (FY 2025) | 1122.0% | Delhi, India |
To see the full peer comparison of Sunrest Lifescience Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Dec 2025 | 101204363 | Others | ₹2.49 Cr | Open | |
| 05 Jun 2025 | 101124224 | Bank of India | ₹9.9 Cr | Open | |
| 25 Oct 2024 | 101004743 | Others | ₹1.1 Cr | Open | |
| 18 Nov 2023 | 100835150 | Axis Bank Limited | ₹3 Cr | Open |
Total charge records: 4 View all charges
Deals & funding
Sunrest Lifescience Limited has 2 deals on record (1 ipo, 1 secondary share transfer); the latest was in November 2023.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2023 | IPO | ₹10.85 Cr | Investors: Public Market Investors |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sunrest Lifescience Limited has 4 court cases on record: 3 filed by Sunrest Lifescience, 1 filed against it. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by Smartway Wellness Private Limited | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against individuals | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against K C Pharma and 1 other | Pending |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed by the company against K C Pharma and 1 other | Disposed |
To see the full case history of Sunrest Lifescience Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sunrest Lifescience Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sunrest Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAZCS4070Q1ZE | Gujarat | Active | 08 Nov 2017 |
To see the full GST registrations and return filing status of Sunrest Lifescience Limited, buy the company report.
Recent activity
Sunrest Lifescience Limited has 13 board changes on record since 2017: 6 appointments and 7 cessations. The latest: Amitbhai Shambhulal Thakkar ceased to be Director on 04 Mar 2023.
8 earlier events are in the company report.
Frequently asked questions
Sunrest Lifescience is an active public limited company based in Ahmedabad, Gujarat, India. The company works in wholesale, within the trading industry. It was incorporated on 30 October 2017 (9+ years old) and is registered under CIN L74999GJ2017PLC099606. Listed on NSE: SUNREST.
Sunrest Lifescience reported revenue of ₹70.83 Cr for FY 2025-26 (up 112% YoY) based on consolidated financials.
Sunrest Lifescience has 6 current directors:
- Nikhilkumar Yashvntlal Thakkar - Managing Director
- Amitbhai Shambhulal Thakkar - Whole-Time Director
- Bhagyesh Kiritbhai Parekh - Director
- Bharatkumar Vardhilal Thakkar - Director
- Juhi Sawajani - Director
- Avani Ashwinkumar Shah - Director
The latest financial statements of Sunrest Lifescience on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 07 September 2026. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Sunrest Lifescience is 24AAZCS4070Q1ZE, registered in Gujarat.
The CIN (Corporate Identification Number) of Sunrest Lifescience is L74999GJ2017PLC099606. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Sunrest Lifescience is a listed company as per MCA records. Its shares are listed on NSE (symbol: SUNREST).
Sunrest Lifescience has 4 court cases on record: 3 filed by the company and 1 filed against it. 2 are pending.
Sunrest Lifescience was incorporated on 30 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Sunrest Lifescience has 2 deals on record (1 ipo, 1 secondary share transfer); the latest was in November 2023.
The peers of Sunrest Lifescience by revenue are Pesino Pharmaceuticals Private Limited, Gattani Metals Private Limited, Gopnath Gold Mint Private Limited, Celestial Industries Private Limited, Shivansh Autozone Private Limited and 5 more, all in the same principal business activity (wholesale trading).